Yuyu Pharma Inc (000227) — Capital Reinvestment Ratio
Latest as of September 2025:
1.75x
Yuyu Pharma Inc (000227) has a Capital Reinvestment Ratio of 1.75x as of September 2025, meaning it reinvests 2% of its operating cash flow (₩836.62 Million) in capital expenditures (₩1.46 Billion). See 000227 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.75x
Capex / Operating Cash Flow
Operating Cash Flow
₩836.62 Million
KRW
Capital Expenditures
₩1.46 Billion
KRW
Data as of
Sep 2025
Most recent filing
Yuyu Pharma Inc Capital Reinvestment Ratio (2014–2024)
This chart tracks Yuyu Pharma Inc's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for Yuyu Pharma Inc (2014–2024)
Year-by-year Capital Reinvestment Ratio for Yuyu Pharma Inc from 2014 to 2024. For live market cap and broader valuation context, see how much is Yuyu Pharma Inc worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.29x | ₩24.95 Billion | ₩7.30 Billion | ▼ -97.6% |
| 2023 | 12.13x | ₩420.86 Million | ₩5.11 Billion | ▲ +800.7% |
| 2021 | 1.35x | ₩4.51 Billion | ₩6.07 Billion | ▲ +120.5% |
| 2019 | 0.61x | ₩13.19 Billion | ₩8.06 Billion | ▼ -61.8% |
| 2018 | 1.60x | ₩6.11 Billion | ₩9.76 Billion | ▼ -82.7% |
| 2017 | 9.25x | ₩561.35 Million | ₩5.19 Billion | ▲ +3819.4% |
| 2016 | 0.24x | ₩9.82 Billion | ₩2.32 Billion | ▼ -20.4% |
| 2014 | 0.30x | ₩1.36 Billion | ₩404.37 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow